Europe Enteral Feeding Formula Market, By Product (Standard Formulas and Disease-Specific Formulas), Application (Oncology, Neurology, Critical Care, Diabetes, Gastroenterology and Others) Type of Tube Feeding (Gastric Tube Feeding, Nasogastric Tube Feeding, Gastrostomy Tube Feeding and Duodenal or Jejunal Tube Feeding), Stage (Adult and Paediatric), End User (Hospitals and Long Term Care Facilities) – Industry Trends and Forecast to 2029
Market Analysis and Size
According to the World Health Organization, low- and middle-income nations account for over 70% of cancer deaths. The Europe enteral feeding formula market is expanding as a result of rising chronic diseases and disorders, a fast ageing population, a rising prevalence of premature birth, rising health-care costs, and increased demand for home care. In 2015, chronic diseases such as cancer, the world's second largest cause of death, claimed the lives of 8.8 million people.
Data Bridge Market Research analyses that the enteral feeding formula market which was USD 6.2 billion in 2021, would rocket up to USD 9.17 billion by 2029, and is expected to undergo a CAGR of 5.01% during the forecast period 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
2022 to 2029
2020 (Customizable to 2019 - 2014)
Revenue in USD Billion, Volumes in Units, Pricing in USD
Product (Standard Formulas and Disease-Specific Formulas), Application (Oncology, Neurology, Critical Care, Diabetes, Gastroenterology and Others) Type of Tube Feeding (Gastric Tube Feeding, Nasogastric Tube Feeding, Gastrostomy Tube Feeding and Duodenal or Jejunal Tube Feeding), Stage (Adult and Pediatric), End User (Hospitals and Long Term Care Facilities)
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Market Players Covered
Nutricia (Netherlands), Hormel Foods Corporation (U.S), Medline Industries, Inc. (U.S), Mead Johnson & Company, LLC. (U.S), Nestlé Health Science (Switzerland), Abbott (U.S), Meiji Holdings Co., Ltd. (Japan), Fresenius Kabi AG (Germany), B. Braun Melsungen AG (Germany), EuropeHealth Product Inc. (U.S), Trovita Health Science (U.S), Victus Inc. (U.S), Avanos Medical Inc. (U.S), Cardinal Health (U.S), Moog Inc (U.S), Conmed Corporation (U.S), Cook Medical (Indiana)
Enteral tube feeding is the introduction of nutrients by tubes into the gut or stomach for individuals who are unable to satisfy their nutritional needs or who are unable to absorb oral nutrients. For enteral feed formula, tubes such as the nasojejunal tube, gastrostomy, nasogastric tube, and jejunostomy are available. The many ways utilized in the delivery of the required nutrients are cost-effective, nutritious, and a viable alternative to the invasive procedure.
Enteral Feeding Formula Market Dynamics
- Rising cases of chronic diseases across globe
The primary drivers that have fuelled the market demand in the projection period are technological advancements in enteral feeding formula. For patients with surgical damage, lactose tolerance, burns, ulcers, and other problems, the formula, which is rooted in the body, is mainly constituted of different minerals and proteins such as fibres, vitamins, proteins, and others. With more preterm deliveries and the development of more technologically advanced enteral feeding formula, demand for enteral feeding formula has increased compared to the previous year. In addition, demand for enteral feeding formula has surged as people throughout the world become more health concerned.
- Rise in the geriatric population
Europe is witnessing a steady increase in the geriatric population, which has resulted in an increase in chronic diseases in the region. The EU-27's growing geriatric population (those aged 85 and up) has a number of consequences. The expense of providing proper health and long-term care is one of the primary areas of worry for the concerned authority, as extremely old people tend to require proportionally more social services. Furthermore, the senior population, which is affected by neurological disorders such as multiple sclerosis, stroke, and dementia that inhibits swallowing, is the largest target audience for this market.
- Expansion in Product Portfolio
Major market players' development of product portfolios is credited with driving growth in the Europe market for enteral feeding formulae. Leading pharmaceutical and nutraceutical firms are investing heavily in research and development (R & R&D), resulting in product breakthroughs moving the market forward. The advent of ready-to-drink (RTD) products, ready-to-use nutritional supplements, and improvements in tube quality are all contributing to the market's growth.
- New Product Launches in the Enteral Feeding Devices
In Europe, the enteral feeding devices market has seen new product introductions in recent years, and these unique product innovations are proving to be a part of the enteral feeding devices market's tremendous potential opportunities. Furthermore, technical advances and product innovations are some of the major factors driving the growth of the enteral feeding formula market. The market's growth is being aided by key players' diverse product portfolios and robust product developments. Some of the product categories that have gained traction in recent years include ready-to-drink (RTD), ready-to-use nutritional supplements, tube feed, and tube feed for certain specialized purposes.
- Complications associated with enteral feeding devices
According to the National Center for Biotechnology Information of the United States National Library of Medicine, gastrostomy and/or jejunostomy feeding tubes are routinely implanted and used for long-term home enteral nutrition support. Although the insertion of these tubes is usually associated with modest morbidity, their long-term usage can lead to a variety of difficulties and disorders that can impair quality of life and have considerable financial implications. All of these issues contribute to the region's limited growth in the Enteral Feeding Devices market.
This enteral feeding formula market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the enteral feeding formula market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Enteral Feeding Formula Market
As good supportive care remains the cornerstone in managing critically ill patients with COVID-19 infection, nutritional management of ICU admitted COVID-19 patients is an integral component of supportive measures, the COVID-19 outbreak is expected to have an impact on the enteral feeding formulas market. According to a study published in the Society of Critical Care Medicine and the American Society for Parenteral and Enteral Nutrition, starting early enteral nutrition (EN) within 24-36 hours of admission to the ICU or within 12 hours of incubation and placement on mechanical ventilation is recommended in the treatment of COVID-19 patients.
According to GLOBOCON 2020, there will be 2,281,658 new cancer cases diagnosed in the United States in 2020, with 612,390 deaths. Breast cancer had the greatest incidence of all malignancies in the United States in 2020, with 253,465 cases, followed by lung (227,875), prostate (209,512), and colon (101,809) new cancer cases.
According to the American Hospital Association's Fast Facts on US Hospitals, 2021, US hospitals reported 36,241,815 admissions in 2019, costing USD 1,161,032,419,000. As a result, all of the aforementioned factors are projected to propel the industry forward.
Europe Enteral Feeding Formula Market Scope
The enteral feeding formula market is segmented on the basis of product, stage, type of tube feeding, indication and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Standard formula
- Disease-specific formula
- Nutrition Deficiency
- Cancer Care
- Chronic Kidney Diseases
- Orphan Diseases
- Pain Management
- Malabsorption/GI Disorder/Diarrhoea
Type of Tube Feeding
- Gastric Tube Feeding
- Nasogastric Tube Feeding
- Gastrostomy Tube Feeding
- Duodenal or Jejunal Tube Feeding
- Critical Care (ICU)
- Home Care
Enteral Feeding Formula Market Regional Analysis/Insights
The enteral feeding formula market is analysed and market size insights and trends are provided by country, product, stage, type of tube feeding, indication and end user as referenced above.
The countries covered in the enteral feeding formula market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The enteral feeding formula market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for enteral feeding formula market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the enteral feeding formula market. The data is available for historic period 2010-2020.
Competitive Landscape and Enteral Feeding Formula Market Share Analysis
The enteral feeding formula market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Europe presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to enteral feeding formula market.
Some of the major players operating in the enteral feeding formula market are:
- Nutricia (Netherlands)
- Hormel Foods Corporation (U.S)
- Medline Industries, Inc. (U.S)
- Mead Johnson & Company, LLC. (U.S)
- Nestlé Health Science (Switzerland)
- Abbott (U.S)
- Meiji Holdings Co., Ltd. (Japan)
- Fresenius Kabi AG (Germany)
- B. Braun Melsungen AG (Germany)
- EuropeHealth Product Inc. (U.S)
- Trovita Health Science (U.S)
- Victus Inc. (U.S)
- Avanos Medical Inc. (U.S)
- Cardinal Health (U.S)
- Moog Inc (U.S)
- Conmed Corporation (U.S)
- Cook Medical (Indiana)